Загрузка...
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
Psoriasis is a chronic immune-mediated skin disease affecting multiple systems, and tumor necrosis factor-α (TNF-α) plays a significant role in the initiation and progression of the disease process. Psoriasis has a high prevalence rate in the Western world, especially in the USA and Australia; in Ch...
Сохранить в:
| Опубликовано в: : | Drug Des Devel Ther |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661374/ https://ncbi.nlm.nih.gov/pubmed/31413544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S200147 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|